Top

Breast Cancer Research and Treatment

Published in:

01-01-1998

Posttraumatic distress symptoms in operable breast cancer III:

Authors: Lars Tjemsland, Jon Arne Søreide, Ulrik Fredrik Malt

Published in: Breast Cancer Research and Treatment | Issue 2/1998

Title: Posttraumatic distress symptoms in operable breast cancer III:
Authors: Lars Tjemsland
Jon Arne Søreide
Ulrik Fredrik Malt
Publication date: 01-01-1998
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/1998
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1005957302990

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/1998

Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors

Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15

Insulin and related factors in premenopausal breast cancer risk

Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells

Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice

Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene:

Keynote webinar | Spotlight on antibody–drug conjugates in cancer